FDA establishment 3005890633, Selaqui, India. Part of Intas Pharmaceuticals's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| Ended | Product and area | Citations | Classification |
|---|---|---|---|
| Sep 16, 2025 | Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Product | Charges | Latest |
|---|---|---|
| TERBINAFINE HYDROCHLORIDE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDJ52 | Feb 5, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports